ProPhase Labs to Present at August 20th Virtual Investor Summit Microcap Event
ProPhase Labs (NASDAQ: PRPH), a next-generation biotech, genomics, and diagnostics company, has announced its participation in the Virtual Investor Summit Microcap Event on August 20th, 2024. The company will deliver a presentation at 1:00 P.M. ET and be available for one-on-one meetings throughout the day.
The event, themed around 50 micro-cap companies with catalysts and/or strong market performance, offers investors an opportunity to engage with ProPhase Labs directly. The presentation will be accessible via webcast, allowing remote participation. This summit provides a platform for in-depth discussions with top investors in the microcap space and includes a live Q&A session.
ProPhase Labs (NASDAQ: PRPH), una società biotech, genomica e diagnostica di nuova generazione, ha annunciato la sua partecipazione all'Evento Virtual Investor Summit Microcap il 20 agosto 2024. L'azienda presenterà una relazione alle 1:00 P.M. ET e sarà disponibile per incontri individuali durante tutta la giornata.
L'evento, incentrato su 50 aziende micro-cap con catalizzatori e/o prestazioni di mercato solide, offre agli investitori l'opportunità di interagire direttamente con ProPhase Labs. La presentazione sarà accessibile tramite webcast, consentendo la partecipazione da remoto. Questo summit fornisce una piattaforma per discussioni approfondite con i principali investitori nel settore microcap e include una sessione di domande e risposte dal vivo.
ProPhase Labs (NASDAQ: PRPH), una empresa de biotecnología, genómica y diagnóstico de nueva generación, ha anunciado su participación en el Evento Virtual Investor Summit Microcap el 20 de agosto de 2024. La compañía realizará una presentación a las 1:00 P.M. ET y estará disponible para reuniones uno a uno durante todo el día.
El evento, con el tema de 50 empresas micro-cap con catalizadores y/o un sólido rendimiento en el mercado, ofrece a los inversores la oportunidad de interactuar directamente con ProPhase Labs. La presentación será accesible a través de un webcast, permitiendo la participación remota. Esta cumbre proporciona una plataforma para discusiones en profundidad con los principales inversores en el espacio microcap e incluye una sesión de preguntas y respuestas en vivo.
ProPhase Labs (NASDAQ: PRPH), 차세대 생명공학, 유전체학 및 진단 회사가 2024년 8월 20일에 열리는 가상 투자 서밋 마이크로캡 이벤트에 참가한다고 발표했습니다. 회사는 동부 표준시 오후 1시에 발표를 진행하고 하루 종일 1:1 미팅에 참석할 예정입니다.
이번 이벤트는 50개의 마이크로캡 기업을 주제로 하며, 촉매제와/또는 강력한 시장 실적을 보유한 기업들을 다루어 투자자들에게 ProPhase Labs와 직접 소통할 수 있는 기회를 제공합니다. 발표는 웹캐스트를 통해 접근 가능하여 원격 참여가 가능합니다. 이 정상 회담은 마이크로캡 분야의 주요 투자자들과 심층 논의를 위한 플랫폼을 제공하며, 실시간 Q&A 세션이 포함됩니다.
ProPhase Labs (NASDAQ: PRPH), une société de biotechnologie, de génomique et de diagnostics de nouvelle génération, a annoncé sa participation au Virtual Investor Summit Microcap Event le 20 août 2024. L'entreprise présentera une communication à 13h00 ET et sera disponible pour des réunions individuelles toute la journée.
L'événement, centré sur 50 entreprises micro-cap dotées de catalyseurs et/ou d'une forte performance sur le marché, offre aux investisseurs l'occasion d'interagir directement avec ProPhase Labs. La présentation sera accessible via webcast, permettant une participation à distance. Ce sommet fournit une plateforme pour des discussions approfondies avec de grands investisseurs du secteur microcap et inclut une salle de questions-réponses en direct.
ProPhase Labs (NASDAQ: PRPH), ein Biotechnologie-, Genomik- und Diagnosetechnologieunternehmen der nächsten Generation, hat seine Teilnahme am Virtuellen Investor Summit Microcap Event am 20. August 2024 bekannt gegeben. Das Unternehmen wird um 13:00 Uhr ET eine Präsentation halten und steht den ganzen Tag über für Einzelgespräche zur Verfügung.
Das Event, das sich um 50 Micro-Cap-Unternehmen mit Katalysatoren und/oder starker Marktleistung dreht, bietet Investoren die Möglichkeit, direkt mit ProPhase Labs in Kontakt zu treten. Die Präsentation wird über einen Webcast verfügbar sein, der eine Teilnahme aus der Ferne ermöglicht. Dieser Gipfel bietet eine Plattform für vertiefte Diskussionen mit führenden Investoren im Microcap-Bereich und beinhaltet eine live Q&A-Sitzung.
- None.
- None.
GARDEN CITY, NY, Aug. 19, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics, and diagnostics company, today announced that it will be presenting at the Virtual Investor Summit Microcap Event. The company will be available for 1-on-1 meetings throughout the day in addition to their presentation.
Event: Q3 Investor Summit
Date: August 20th, 2024
Presentation Time: 1:00 P.M. ET
Location: https://www.webcaster4.com/Webcast/Page/3062/51116
- The theme is 50 micro-cap companies with a catalyst and/or strong performance in the current market.
- Take a deep dive with the best Investors in MicroCap
- Live Q & A
- Complimentary to Qualified Investors. Please REGISTER HERE.
About ProPhase Labs
ProPhase Labs Inc. (Nasdaq: PRPH) (“ProPhase”) is a next-generation biotech, genomics and diagnostics company. Our goal is to create a healthier world with bold action and the power of insight. We’re revolutionizing healthcare with industry-leading Whole Genome Sequencing solutions, while developing potential game changer diagnostics and therapeutics in the fight against cancer. This includes a potentially life-saving cancer test focused on early detection of esophageal cancer and potential breakthrough cancer therapeutics with novel mechanisms of action. Our world-class CLIA labs and cutting-edge diagnostic technology provide wellness solutions for healthcare providers and consumers. We develop, manufacture, and commercialize health and wellness solutions to enable people to live their best lives. We are committed to executional excellence, smart diversification, and a synergistic, omni-channel approach. ProPhase Labs’ valuable subsidiaries, their synergies, and significant growth underscore our multi-billion-dollar potential.
For more information, visit www.ProPhaseLabs.com.
Media Relations and Institutional Investor Contact:
ProPhase Labs, Inc.
267-880-1111
investorrelations@prophaselabs.com
Retail Investor Relations Contact:
Renmark Financial Communications
John Boidman
514-939-3989
Jboidman@renmarkfinancial.com
FAQ
When is ProPhase Labs (PRPH) presenting at the Virtual Investor Summit Microcap Event?
What type of meetings will ProPhase Labs (PRPH) be available for during the Virtual Investor Summit?
How can investors access ProPhase Labs' (PRPH) presentation at the Virtual Investor Summit?
What is the theme of the Virtual Investor Summit Microcap Event featuring ProPhase Labs (PRPH)?
